EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation

Rami Al-Dwairi, Tamam El-Elimat iD, Abdelwahab Aleshawi, Ahmed H Al Sharie, Balqis M Abu Mousa, Seren Al Beiruti, Ahmad Alkazaleh, Hasan Mohidat

Biomolecules · 2023

DOI: 10.3390/biom13111630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Rami Al-Dwairi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Retinopathy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jordan University of Science and Technology, JUST, Irbid, Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The global epidemic status of diabetic retinopathy (DR) and its burden presents an ongoing challenge to health-care systems. It is of great interest to investigate potential prognostic biomarkers of DR. Such markers could aid in detecting early stages of DR, predicting DR progression and its response to therapeutics. Herein, we investigate the prognostic value of intravitreal concentrations of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) in a DR cohort. Materials and methods: Vitreous sample acquisition was conducted at King Abdullah University Hospital (KAUH) between December 2020 and June 2022. Samples were obtained from any patient scheduled to undergo a pars plana vitrectomy (PPV) for any indication. Included patients were categorized into a DR group or a corresponding non-diabetic (ND) control group. Demographics, clinicopathological variables, standardized laboratory tests results, and optical coherence tomography (OCT) data were obtained for each included individual. Intravitreal concentrations of VEGF and PDGF were assessed using commercial enzyme-linked immunosorbent assay (ELISA).

Results

A total of 80 eyes from 80 patients (DR group: n = 42 and ND control group: n = 38) were included in the analysis. The vitreous VEGF levels were significantly higher in the DR group compared to the ND control group (DR group 5744.06 ± 761.5 pg/mL versus ND control group 817.94 ± 403.1 pg/mL, p = 0.0001). In addition, the vitreous PDGF levels were also significantly higher in the DR group than those in the ND control group (DR group 4031.51 ± 410.2 pg/mL versus ND control group 2691.46 ± 821.0 pg/mL, p = 0.001). Bassline differences between test groups and clinical factors impacting VEGF and PDGF concentrations were investigated as well. Multiple regression analysis indicated PDGF as the sole independent risk factor affecting best-corrected visual acuity (BCVA) at the last follow-up visit: the higher the PDGF vitreous levels, the worst the BCVA.

Conclusions

Vitreous concentrations of VEGF and PDGF are correlated with DR severity and may exhibit a possible prognostic potential value in DR. Further clinical and experimental data are warranted to confirm the observed findings and to help incorporate them into daily practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic RetinopathyHumansPlatelet-Derived Growth FactorVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsVitreous Body

Stichwörter der Autor:innen

PDGFVEGFdiabetic retinopathyintravitreal concentrationsplatelet-derived growth factorvascular endothelial growth factorvisual outcomes

Substanzen

Platelet-Derived Growth FactorVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsVEGFA protein, human

Autor:innen und Institutionen

  • Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  • Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.
  • Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.

ORCID-Profile: Tamam El-Elimat

Förderung

  • Jordan University of Science and Technology
  • JUST, Irbid, Jordan

Zitieren

APA

Al-Dwairi, R., El-Elimat, T., Aleshawi, A., Al Sharie, A. H., Abu Mousa, B. M., Al Beiruti, S., Alkazaleh, A., & Mohidat, H. (2023). Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation. Biomolecules. https://doi.org/10.3390/biom13111630

Vancouver

Al-Dwairi R, El-Elimat T, Aleshawi A, Al Sharie AH, Abu Mousa BM, Al Beiruti S, et al. Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation. Biomolecules. 2023. doi:10.3390/biom13111630

BibTeX
@article{AlDwairi2023,
  author = {Al-Dwairi, Rami and El-Elimat, Tamam and Aleshawi, Abdelwahab and Al Sharie, Ahmed H and Abu Mousa, Balqis M and Al Beiruti, Seren and Alkazaleh, Ahmad and Mohidat, Hasan},
  title = {Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13111630}
}
Kostenlos starten →